1. Home
  2. AVDL vs AVNS Comparison

AVDL vs AVNS Comparison

Compare AVDL & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • AVNS
  • Stock Information
  • Founded
  • AVDL 2015
  • AVNS 2014
  • Country
  • AVDL Ireland
  • AVNS United States
  • Employees
  • AVDL N/A
  • AVNS N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • AVNS Industrial Specialties
  • Sector
  • AVDL Health Care
  • AVNS Health Care
  • Exchange
  • AVDL Nasdaq
  • AVNS Nasdaq
  • Market Cap
  • AVDL 784.6M
  • AVNS 641.7M
  • IPO Year
  • AVDL 1996
  • AVNS N/A
  • Fundamental
  • Price
  • AVDL $9.39
  • AVNS $12.64
  • Analyst Decision
  • AVDL Strong Buy
  • AVNS Hold
  • Analyst Count
  • AVDL 7
  • AVNS 1
  • Target Price
  • AVDL $18.86
  • AVNS N/A
  • AVG Volume (30 Days)
  • AVDL 1.3M
  • AVNS 515.5K
  • Earning Date
  • AVDL 05-07-2025
  • AVNS 05-06-2025
  • Dividend Yield
  • AVDL N/A
  • AVNS N/A
  • EPS Growth
  • AVDL N/A
  • AVNS N/A
  • EPS
  • AVDL N/A
  • AVNS N/A
  • Revenue
  • AVDL $194,450,000.00
  • AVNS $689,200,000.00
  • Revenue This Year
  • AVDL $50.53
  • AVNS N/A
  • Revenue Next Year
  • AVDL $32.33
  • AVNS $3.36
  • P/E Ratio
  • AVDL N/A
  • AVNS N/A
  • Revenue Growth
  • AVDL 252.64
  • AVNS 1.34
  • 52 Week Low
  • AVDL $6.38
  • AVNS $11.84
  • 52 Week High
  • AVDL $17.85
  • AVNS $25.36
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 64.66
  • AVNS 46.27
  • Support Level
  • AVDL $8.55
  • AVNS $12.35
  • Resistance Level
  • AVDL $9.98
  • AVNS $13.31
  • Average True Range (ATR)
  • AVDL 0.51
  • AVNS 0.44
  • MACD
  • AVDL 0.10
  • AVNS 0.12
  • Stochastic Oscillator
  • AVDL 72.04
  • AVNS 50.92

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Share on Social Networks: